|
CCDC76 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.659500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.438120E-02 |
| Normal-vs-Stage2 |
3.039800E-02 |
| Normal-vs-Stage3 |
4.462200E-02 |
| Normal-vs-Stage4 |
1.979390E-01 |
| Stage1-vs-Stage2 |
3.410000E-01 |
| Stage1-vs-Stage3 |
9.171400E-01 |
| Stage1-vs-Stage4 |
4.266800E-01 |
| Stage2-vs-Stage3 |
3.826200E-01 |
| Stage2-vs-Stage4 |
1.790560E-01 |
| Stage3-vs-Stage4 |
4.594200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.178130E-02 |
| Normal-vs-AfricanAmerican |
3.328200E-02 |
| Normal-vs-Asian |
2.561000E-03 |
| Caucasian-vs-AfricanAmerican |
5.046200E-01 |
| Caucasian-vs-Asian |
2.018200E-01 |
| AfricanAmerican-vs-Asian |
2.867800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.197600E-02 |
| Normal-vs-Female |
1.878170E-03 |
| Male-vs-Female |
1.544400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.603200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.444100E-03 |
| Normal-vs-Age(61-80Yrs) |
2.606400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.786600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.769800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.470200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.095800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.184600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.083200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.289600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.362100E-04 |
| Normal-vs-Grade 2 |
3.184800E-04 |
| Normal-vs-Grade 3 |
6.916300E-02 |
| Normal-vs-Grade 4 |
6.537800E-01 |
| Grade 1-vs-Grade 2 |
3.816400E-01 |
| Grade 1-vs-Grade 3 |
4.241700E-02 |
| Grade 1-vs-Grade 4 |
2.579400E-03 |
| Grade 2-vs-Grade 3 |
3.235900E-02 |
| Grade 2-vs-Grade 4 |
3.578600E-04 |
| Grade 3-vs-Grade 4 |
5.482200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.56810000000651E-05 |
| Normal-vs-ccB subtype |
7.094200E-01 |
| ccA subtype-vs-ccB subtype |
1.203930E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.336500E-03 |
| Normal-vs-N1 |
5.312200E-01 |
| N0-vs-N1 |
1.236830E-01 |
|
|
